Unless you’ve recently been in a coma you’ve no doubt heard of the meteoric rise of Bernie Sanders. According to the latest national polls, Senator Sanders, a Democrat from Vermont, is quickly closing the gap with Clinton.
But whether you’re a Republican or a Democrat, Sanders’ supporter or not, one thing has become clear. If you own CVS Health (CVS), beware, because Senator Sanders’ ideas for public health could hit CVS stock in a very big way.
CVS Health, the U.S. pharmaceutical chain, has been quick to recognize the changing demographics in the US. According the U.S. Census Bureau estimate, the population of aging citizens will jump by more than 20 million in 15 years. That means drugs related to common diseases of old age — e.g. diabetes, atherosclerosis, Alzheimer’s, etc. — will be in even higher demand. Read